Orchid Chemicals and Pharmaceuticals and the newly formed, venture capital-financed European biopharmaceutical firm Allecra Therapeutics have entered into a partnership to develop novel antibiotics to treat multidrug resistant bacterial infections.
As part of the deal, Orchid has assigned its intellectual property (IP) related to a lead antibiotic compound to Allecra,...







